Axsome Therapeutics与黑石达成5.7亿美元定期贷款与循环债权安排

投资界综合2025-05-20

投资界（ID：pedaily2012）5月20日消息，生物制药公司Axsome Therapeutics（纳斯达克股票代码：AXSM），作为中枢神经系统（CNS）疾病治疗领域新纪元的开拓者，宣布与黑石生命科学（Blackstone Life Sciences）及黑石债权和保险（Blackstone Credit & Insurance）管理的基金，达成5.7亿美元定期贷款与循环债权安排。这笔价值...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2536666157?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-20 11:48","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2536666157","market":"us","top_or_hot":-1,"title":"Axsome Therapeutics与黑石达成5.7亿美元定期贷款与循环债权安排","media":"投资界综合","content":"<div>\n<p>投资界（ID：pedaily2012）5月20日消息，生物制药公司Axsome Therapeutics（纳斯达克股票代码：AXSM），作为中枢神经系统（CNS）疾病治疗领域新纪元的开拓者，宣布与黑石生命科学（Blackstone Life Sciences）及黑石债权和保险（Blackstone Credit & Insurance）管理的基金，达成5.7亿美元定期贷款与循环债权安排。这笔价值...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520115041a6e57e6f&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Axsome Therapeutics与黑石达成5.7亿美元定期贷款与循环债权安排</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAxsome Therapeutics与黑石达成5.7亿美元定期贷款与循环债权安排\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-20 11:48 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520115041a6e57e6f&s=b><strong>投资界综合</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>投资界（ID：pedaily2012）5月20日消息，生物制药公司Axsome Therapeutics（纳斯达克股票代码：AXSM），作为中枢神经系统（CNS）疾病治疗领域新纪元的开拓者，宣布与黑石生命科学（Blackstone Life Sciences）及黑石债权和保险（Blackstone Credit & Insurance）管理的基金，达成5.7亿美元定期贷款与循环债权安排。这笔价值...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520115041a6e57e6f&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520115041a6e57e6f&s=b","article_id":"2536666157","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520115041a6e57e6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2536666157","pubTimestamp":1747712880,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"投资界5月20日消息，生物制药公司Axsome Therapeutics，作为中枢神经系统疾病治疗领域新纪元的开拓者，宣布与黑石生命科学及黑石债权和保险管理的基金，达成5.7亿美元定期贷款与循环债权安排。协议达成后，Axsome从定期贷款安排中提取1.2亿美元，用于偿还此前自Hercules Capital获取的定期贷款。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LENZ":"Therapeutics","BK4588":"碎股","IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","BK4007":"制药","BK4585":"ETF&股票定投概念","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","BK4139":"生物科技","BK4505":"高瓴资本持仓","BX":"黑石","IE0004445239.USD":"JANUS HENDERSON US FORTY \"A2\" (USD) ACC","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","AXSM":"Axsome Therapeutics, Inc.","IE00BN8TJ469.HKD":"FTGF CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A\" (HKD) INC","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","BK4135":"资产管理与托管银行","BK4539":"次新股","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC"},"translate_title":"Axsome Therapeutics and Blackstone reach $570 million term loan and revolving claims arrangement","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"AXSM":0.9,"BX":1},"content_text":"投资界（ID：pedaily2012）5月20日消息，生物制药公司Axsome Therapeutics（纳斯达克股票代码：AXSM），作为中枢神经系统（CNS）疾病治疗领域新纪元的开拓者，宣布与黑石生命科学（Blackstone Life Sciences）及黑石债权和保险（Blackstone Credit & Insurance）管理的基金，达成5.7亿美元定期贷款与循环债权安排。这笔价值5.7亿美元的新债权安排包括一项5亿美元的定期贷款安排和一项7000万美元的循环债权安排。协议达成后，Axsome从定期贷款安排中提取1.2亿美元，用于偿还此前自Hercules Capital获取的定期贷款。Axsome Therapeutics 首席执行官Herriot Tabuteau博士表示：“黑石在生命科学领域造诣深厚，我们很荣幸能与之合作。此次达成的新协议不仅使我们的可用债权额度增加超2亿美元，同时显著降低了我们的资本成本。新债权安排的优化条款彰显我们加速实现盈利和提升股东回报的决心，同时凸显我们致力于改善中枢神经系统疾病患者生活的使命。”黑石生命科学高级董事总经理Craig Shepherd和Kiran Reddy博士表示：“在 Axsome 迎来增长与商业机遇拓展之际，黑石深感荣幸能够与之携手合作。此次投资旨在增强Axsome的运营与财务灵活性，为其下一阶段的持续增长提供助力，同时也体现了黑石为*生物制药公司提供定制化的灵活融资方案、助力其实现战略目标的强大能力。”黑石债权和保险医疗健康业务全球主管Brad Colman补充道：“Axsome拥有成功的商业经验、创新的研发管线和实力强劲的领导团队，是我们投资变革性疗法、造福患者的理想选择。这笔交易充分证明了我们能够为世界一流的生命科学公司提供规模化融资解决方案的强劲实力。”","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2536666157","isCrawlerRequest":true}